Select Page

CJD Risk Classification

Home Forums Infexion Connexion CJD Risk Classification

 | Click to Receive Email Notifications of Posts
Viewing 4 posts - 1 through 4 (of 4 total)
  • Author
    Posts
  • #69744
    Avatar photoMichael Wishart
    Participant

    Author:
    Michael Wishart

    Position:
    Infection Control Coordinator

    Organisation:
    St Vincent's Private Hospital Northside

    State:
    QLD

    [Posted on behalf of Kathy Wilson – Moderator]

    Hi,
    Just need some clarification on the classification of high risk and low
    risk patients, Appendix 1 (high risk)under accidentally transmitted
    risk factors include treatment with human cadaver pituitary growth
    hormone, gonadotrophin or human dura mater graft and exposure to
    surgical instruments that have come into contact with higher infectivity
    tissues previously used in a case of definite or probable human prion
    disease. And in Appendix 2 (low risk) Recipients of cadaver-derived
    human pituitary hormones before 1986 Dura mater grafts before 1990 and
    individuals involved in a lock back from exposure to surgical
    instruments that have been used on high or medium infective tissue from
    patients later to be found to have contracted CJD.
    What determines if these patients are high risk or low risk?

    Kathy Wilson
    Castle Hill Day Surgery
    72-74 Cecil Ave Castle Hill
    NSW 2154
    Phone 02 88500500
    Fax 02 88503011

    Messages posted to this list are solely the opinion of the authors, and do not represent the opinion of ACIPC.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    Michael Wishart
    Infection Control Coordinator
    St Vincent's Private Hospital Northside & St Vincent's Private Hospital Brisbane
    Brisbane, QLD
    michael.wishart@svha.org.au

    #69745
    Jackie Miley
    Participant

    Author:
    Jackie Miley

    Position:

    Organisation:

    State:

    Dear Kathy
    I am aware that guidelines differ across the water (!) but herewith a link
    to the UK guidelines.
    Risk is generally assessed from a number of perspectives, eg what kind of
    surgery is being proposed, what surgery has been undertaken previously,
    etc etc.

    http://www.dh.gov.uk/health/2012/11/acdp-guidance/

    There may be some useful information/definitions here.

    Kind regards

    *Jackie *

    *Jackie Miley* MSc, PG Cert Public Health, Cert Infection Control,
    Dip Rn.

    Senior Lecturer Infection Prevention and Control
    Course Leader MSc Infection Prevention and Control
    Course Leader Short Course Infection Prevention & Control

    Oxford Brookes University
    Faculty of Health and Life Sciences
    Department of Biological and Medical Sciences
    Jack Straw’s Lane
    Marston
    Oxford OX3 0FL

    jmiley@brookes.ac.uk

    On 25 February 2013 10:08, Michael Wishart wrote:

    > [Posted on behalf of Kathy Wilson – Moderator]
    >
    > Hi,
    > Just need some clarification on the classification of high risk and low
    > risk patients, Appendix 1 (high risk)under accidentally transmitted risk
    > factors include treatment with human cadaver pituitary growth hormone,
    > gonadotrophin or human dura mater graft and exposure to surgical
    > instruments that have come into contact with higher infectivity tissues
    > previously used in a case of definite or probable human prion disease. And
    > in Appendix 2 (low risk) Recipients of cadaver-derived human pituitary
    > hormones before 1986 Dura mater grafts before 1990 and individuals
    > involved in a lock back from exposure to surgical instruments that have
    > been used on high or medium infective tissue from patients later to be
    > found to have contracted CJD.
    > What determines if these patients are high risk or low risk?
    >
    > Kathy Wilson
    > Castle Hill Day Surgery
    > 72-74 Cecil Ave Castle Hill
    > NSW 2154
    > Phone 02 88500500
    > Fax 02 88503011
    >
    > Messages posted to this list are solely the opinion of the authors, and do
    > not represent the opinion of ACIPC.
    >
    > Archive of all messages are available at http://aicalist.org.au/**archives- registration and login required.
    >
    > Replies to this message will be directed back to the list. To create a new
    > message send an email to aicalist@aicalist.org.au
    >
    > To send a message to the list administrator send an email to
    > aicalist-request@aicalist.org.**au .
    >
    > You can unsubscribe from this list be sending ‘signoff aicalist’ (without
    > the quotes) to listserv@aicalist.org.au
    >

    Messages posted to this list are solely the opinion of the authors, and do not represent the opinion of ACIPC.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    #69746
    Michael Wishart
    Participant

    Author:
    Michael Wishart

    Position:

    Organisation:

    State:

    Hi Kathy

    I believe the difference here is symptoms. It is difficult to quantify the risk of transmission in these instances, but if symptoms are present then the risk transmission has occurred is markedly increased. Tihs group of patients has not yet been diagnosed with CJD, but are a possibility because of their possible risk of previous exposure, hence high risk.

    No symptoms leaves them in a low risk.

    That is how I have always understood this, anyway.

    Cheers
    Michael

    Michael Wishart
    CNC Infection Control
    Holy Spirit Northside Private Hospital
    627 Rode Road, Chermside, Qld 4032
    t: (07) 3326 3068 | f: (07) 3326 3523
    e: Michael.Wishart@hsn.org.au
    w:www.holyspiritnorthside.org.au
    Please consider the environment before printing this email

    ________________________________________

    [Posted on behalf of Kathy Wilson – Moderator]

    Hi,
    Just need some clarification on the classification of high risk and low
    risk patients, Appendix 1 (high risk)under accidentally transmitted
    risk factors include treatment with human cadaver pituitary growth
    hormone, gonadotrophin or human dura mater graft and exposure to
    surgical instruments that have come into contact with higher infectivity
    tissues previously used in a case of definite or probable human prion
    disease. And in Appendix 2 (low risk) Recipients of cadaver-derived
    human pituitary hormones before 1986 Dura mater grafts before 1990 and
    individuals involved in a lock back from exposure to surgical
    instruments that have been used on high or medium infective tissue from
    patients later to be found to have contracted CJD.
    What determines if these patients are high risk or low risk?

    Kathy Wilson
    Castle Hill Day Surgery
    72-74 Cecil Ave Castle Hill
    NSW 2154
    Phone 02 88500500
    Fax 02 88503011

    Messages posted to this list are solely the opinion of the authors, and do not represent the opinion of ACIPC.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    Message protected by MailGuard: e-mail anti-virus, anti-spam and content filtering.http://www.mailguard.com.au/mg
    Click here to report this message as spam:
    https://login.mailguard.com.au/report/1GDE84tjin/5ZF2OdxYYCUmTbdEz7hXP0/0.79

    Messages posted to this list are solely the opinion of the authors, and do not represent the opinion of ACIPC.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    #69752
    Michele.Cullen@HEALTH.VIC.GOV.AU Subject: Re: CJD Risk Classification Comments: cc: ann.koehler@health.sa.gov.au In-Reply-To:
    Participant

    Author:
    Michele.Cullen@HEALTH.VIC.GOV.AU Subject: Re: CJD Risk Classification Comments: cc: ann.koehler@health.sa.gov.au In-Reply-To:

    Position:

    Organisation:

    State:

    Dear All,

    As a member of the writing group on the CJD guidelines can I direct you to
    the following sections for clarification on this issue.

    Section 2 on assessing the risk particularly Table 1 which lists the known
    infectivity of tissues (risk)
    Section 2.3 which describes the risk categories for patients
    Section 2.4 on risk assessment and Table 2
    The appendices 1 & 2 expand on the above, and are for additional
    information

    What do you need to know:
    a) Is the patient having a high risk tissue procedure
    b) Do they have any S&S or have reported them – high risk patient
    c) Do they fall into the lower risk category – that is a potential risk of
    CJD
    d) Are they background risk – that is, the rest of the population
    (1:1,000,000 background risk)

    Depending on the above the medical officer should use the questionnaire
    (Appendix 3) to further assess the risk and then inform the HCF about any
    additional needs BEFORE surgery. This should be conveyed to the OR team to
    give them sufficient time to facilitate single use instruments and other
    arrangements where available/appropriate to PREVENT unnecessary delays in
    surgery and to stop patients being held up in admissions, the ward or worse
    (it has occurred) at the OR door.

    Theroetical risk for those involved in look-backs – classed as low because
    it is thought they may have a slightly higher risk than background (it is
    theoretical) but are not as ‘at risk’ as those who have been exposed to
    pituitary hormones who are definitely low risk

    Depending on initial risk (S&S, hormone treatment, look-back links etc) and
    the type of surgical procedure (table 2) you should be able to categorise
    the patient and the risk.
    As Michael stated with high risk patients it is about S&S.
    Low risk patients having high risk tissue surgery move up to high risk
    patients even without S&S.

    I hopes this clarifies the issue

    Michael, I have copied Dr Ann Koehler into this email as the Chair of the
    CJD writing group.

    Regards

    (Embedded (Embedded image moved to file: pic21335.jpg)
    image moved
    to file:
    pic26005.jpg)

    Michele Cullen
    Infection Control Consultant | Communicable Disease Prevention and
    Control | Public Health
    Department of Health | 50 Lonsdale Street, Melbourne, Victoria,
    3000
    p. 03 9096 5094 | f. 1300 651 170
    e. michele.cullen@health.vic.gov.au

    |————>
    | From: |
    |————>
    >————————————————————————————————————————————————–|
    |Michael Wishart |
    >————————————————————————————————————————————————–|
    |————>
    | To: |
    |————>
    >————————————————————————————————————————————————–|
    |AICALIST@AICALIST.ORG.AU |
    >————————————————————————————————————————————————–|
    |————>
    | Date: |
    |————>
    >————————————————————————————————————————————————–|
    |25/02/2013 11:02 PM |
    >————————————————————————————————————————————————–|
    |————>
    | Subject: |
    |————>
    >————————————————————————————————————————————————–|
    |Re: CJD Risk Classification |
    >————————————————————————————————————————————————–|
    |————>
    | Sent by: |
    |————>
    >————————————————————————————————————————————————–|
    |ACIPC Infexion Connexion |
    >————————————————————————————————————————————————–|

    Hi Kathy

    I believe the difference here is symptoms. It is difficult to quantify the
    risk of transmission in these instances, but if symptoms are present then
    the risk transmission has occurred is markedly increased. Tihs group of
    patients has not yet been diagnosed with CJD, but are a possibility because
    of their possible risk of previous exposure, hence high risk.

    No symptoms leaves them in a low risk.

    That is how I have always understood this, anyway.

    Cheers
    Michael

    Michael Wishart
    CNC Infection Control
    Holy Spirit Northside Private Hospital
    627 Rode Road, Chermside, Qld 4032
    t: (07) 3326 3068 | f: (07) 3326 3523
    e: Michael.Wishart@hsn.org.au
    w:www.holyspiritnorthside.org.au
    Please consider the environment before printing this email

    ________________________________________
    Michael Wishart [michael.wishart@internode.on.net]

    [Posted on behalf of Kathy Wilson – Moderator]

    Hi,
    Just need some clarification on the classification of high risk and low
    risk patients, Appendix 1 (high risk)under accidentally transmitted
    risk factors include treatment with human cadaver pituitary growth
    hormone, gonadotrophin or human dura mater graft and exposure to
    surgical instruments that have come into contact with higher infectivity
    tissues previously used in a case of definite or probable human prion
    disease. And in Appendix 2 (low risk) Recipients of cadaver-derived
    human pituitary hormones before 1986 Dura mater grafts before 1990 and
    individuals involved in a lock back from exposure to surgical
    instruments that have been used on high or medium infective tissue from
    patients later to be found to have contracted CJD.
    What determines if these patients are high risk or low risk?

    Kathy Wilson
    Castle Hill Day Surgery
    72-74 Cecil Ave Castle Hill
    NSW 2154
    Phone 02 88500500
    Fax 02 88503011

    Messages posted to this list are solely the opinion of the authors, and do
    not represent the opinion of ACIPC.

    Archive of all messages are available at http://aicalist.org.au/archives
    registration and login required.

    Replies to this message will be directed back to the list. To create a new
    message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to
    aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without
    the quotes) to listserv@aicalist.org.au

    Message protected by MailGuard: e-mail anti-virus, anti-spam and content
    filtering.http://www.mailguard.com.au/mg
    Click here to report this message as spam:
    https://login.mailguard.com.au/report/1GDE84tjin/5ZF2OdxYYCUmTbdEz7hXP0/0.79

    Messages posted to this list are solely the opinion of the authors, and do
    not represent the opinion of ACIPC.

    Archive of all messages are available at http://aicalist.org.au/archives
    registration and login required.

    Replies to this message will be directed back to the list. To create a new
    message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to
    aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without
    the quotes) to listserv@aicalist.org.au
    _________________________________________________________________________________

    This email contains confidential information intended only for the person named above and may be subject to legal privilege. If you are not the intended recipient, any disclosure, copying or use of this information is prohibited. The Department provides no guarantee that this communication is free of virus or that it has not been intercepted or interfered with. If you have received this email in error or have any other concerns regarding its transmission, please notify Postmaster@dhs.vic.gov.au
    _________________________________________________________________________________

    Messages posted to this list are solely the opinion of the authors, and do not represent the opinion of ACIPC.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

Viewing 4 posts - 1 through 4 (of 4 total)
  • The forum ‘Infexion Connexion’ is closed to new topics and replies.